Blog - Page 3774 of 5774

MondayOct 04, 2010 1:43 pm

American Petro-Hunter, Inc. (AAPH.OB) Starts Completion of Oklahoma Well

American Petro-Hunter, Inc. reported that the company has begun completion operations on a well at its oil and gas properties in Oklahoma. American Petro-Hunter, Inc. is currently installing a tank battery and pumping unit at the site of the NOJ26 well in order to assist in completion operations. The company intends to fracture stimulate the oil shale to get the well to produce oil. American Petro-Hunter, Inc. said that after the NOJ26 well has been completed, the well would be ready for commercial production. The NOJ26 well is located at the North Oklahoma Oil Project. American Petro-Hunter, Inc. found two…

MondayOct 04, 2010 1:41 pm

Unigene Laboratories, Inc. (UGNE.OB) Expands Leadership Team to Support Peptide Therapeutics Development

Unigene Laboratories, www.unigene.com – a leader in the burgeoning field of peptide-based therapeutics which is aggressively building a robust portfolio of partnerships via its sophisticated Peptelligence™ platform, reported today the expansion of its leadership team (effectively immediately) with the appointment of Gregory T. Mayes to the newly created position of Vice President, Corporate Affairs and General Counsel. Subsequently Roxanne Tavakkol was promoted to the position of VP, Global Regulatory Affairs and both of these appointments will report directly President and CEO, Ashleigh Palmer. This more robust leadership profile will help the Company to fully leverage its Peptelligence platform’s assets which…

MondayOct 04, 2010 1:39 pm

Weikang Bio-Technology Group Co., Inc. (WKBT.OB) Announces Upcoming Launch of Three New Therapeutics

Weikang Bio-Technology Group, www.weikangbio.com – producer of traditional Chinese medicine, health aids, powerful nutritional supplements (all in full compliance with PRC regulatory licensure) and which is actively branching out into herbal extracts as well as GMP-certified western prescription and OTC pharmaceuticals, announced today plans to launch three brand new therapeutics during Q1 FY11. A total projected revenue generation from the new products should exceed $3.1M ($1.1M net) in 2011 and have already received the stamp of approval from the State Food and Drug Administration. Chairman and CEO of WKBT, Mr. Yin Wang, was pleased at the health of the Company…

MondayOct 04, 2010 1:36 pm

CellCyte Genetics Corp. (CCYG.OB) and the Fred Hutchinson Cancer Research Center Sign a Test Collaboration Agreement

CellCyte Genetics Corp. is an emerging biotechnology company engaged in the discovery, development and commercialization of products that enhance the productivity of biotechnology research laboratories. The company's initial product line is comprised of the CCG-E45 culture chamber and related CCG-E45 incubator which have been in experimental use for the last several years. CellCyte announced today that it has signed a beta test collaboration agreement with the Fred Hutchinson Cancer Research Center in Seattle, Washington. The test is intended to evaluate the CCG-E45 culture chamber product as a supplement or replacement to their current methods of culturing specific cell lines. CellCyte's…

MondayOct 04, 2010 12:17 pm

Ecologic Transportation, Inc. (EGCT.OB) is “One to Watch”

Ecologic Transportation, Inc. is a holding company with wholly owned subsidiaries dedicated to environmentally friendly transportation products and services. The Company encompasses three separate but integrated operations that address the environment and transportation holistically. Ecologic Transportation, Inc.’s main operation is the car rental division. Ecologic Transportation, Inc. trades on the OTC Bulletin Board and they have their headquarters in Santa Monica, California. The Ecologic Car Rentals unit engages in car rental operations and offers environmentally friendly vehicles. The Ecologic Systems unit operates as an alternative energy operations unit. It involves the development and management of enhancing and greening gas stations…

MondayOct 04, 2010 10:50 am

Celison (CLSN) Meets FDA Requirements for New Drug Application Submission

Celsion Corp. is a leading oncology drug development company focused on treatments using heat energy and heat-activated drug delivery systems. The company today announced it has come to an agreement with the U.S. Food and Drug Administration (FDA) that acknowledges that the company has met requirements for non-clinical studies for its New Drug Application (NDA) for ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin applicable for the treatment of a wide range of cancers. ThermoDox is currently being evaluated in a 600-patient phase III study at 75 clinical sites to evaluate the drug’s efficacy in combination with radiofrequency ablation (RFA).…

MondayOct 04, 2010 10:28 am

New Energy Systems Group (NEWN) is “One to Watch”

New Energy Systems Group is a vertically integrated original design manufacturer and distributor of lithium ion batteries and backup power systems for mobile phones, laptops, digital cameras, MP3s and a variety of other portable electronics. Engaged in the battery business for many years, New Energy has established a strong network among battery companies and gained extensive experience in battery assembly and distribution. Selling its end-user consumer products primarly under the Anytone brand in China, the company has begun expanding its international sales efforts. Recently New Energy announced plans to launch MeePower(TM), a new brand of advanced battery backup systems and…

MondayOct 04, 2010 9:58 am

Medisafe 1 Technologies Corp. (MFTH.OB) Successfully Tests Prototype of Patented Syringe Locking Device

Medisafe 1 Technologies Corp. seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. The company's patented technology is a medical assembly with a locking mechanism that is intended to ensure that a substance cannot be released from a hypodermic needle without positive pre-matching between the substance and its intended patient. The company today announced positive developments relating to the production of a prototype of its locking device technology. The prototype has successfully passed Medisafe 1 Technologies' preliminary testing phase. The tests confirm the potential of the prototype to significantly reduce preventable drug-related injuries in…

MondayOct 04, 2010 9:55 am

VizStar, Inc. (VIZS.OB) Takes Advantage Of The Economy

Recently, Gary Clyburn, the CEO of VizStar, issued a letter to the investment community outlining the company’s current position and direction. The information presented is critical to anyone considering investing in VizStar, since it reflects the company’s strategy as it relates to the on-going recessionary climate. Unlike many company’s, VizStar is not simply waiting for the economy to improve, but has instead taken specific steps to leverage the current economic crisis to its own advantage. We felt the information was important enough to include here in its entirety. Dear present and many future VizStar shareholders, In the near future, we…

MondayOct 04, 2010 9:00 am

Why Did My Stock Stop Trading?

One of the best characteristics of stocks is that they are almost always easy to trade. If you want to buy or sell some stock, all it takes is a couple mouse clicks or a brief telephone conversation with your broker. But there are times when a stock you're trying to buy or sell isn't accepting orders. A stock may stop trading temporarily if there's important pending news or if trading has been volatile enough to set off "circuit breakers". You can read more about halts on the Securities and Exchange Commission's website: www.sec.gov/answers/tradinghalt.htm. Usually trading is resumed in less…

Site Search

Company Search